Increase in Plasma Concentrationof Plasminogen Activator Inhibitor, Fibrinogen, von Willebrand Factor, Factor VIII: Cand in Erythrocyte Sedimentation Rate with Age

Summary

Elderly patients have previously been shown to have an increased plasma concentration of tissue plasminogen activator (t-PA) antigen (t-PAAg). Since the concentration of t-PA Ag dependson both free t-PA and t-PA complexed with inhibitors, mainly plasminogen activator inhibitor (PA inhibitor), we have investigated the relationship between the plasma concentration of PA inhibitor and age in 20 elderly and 20 young individuals. Elderly individuals showed a slight increase in PA inhibitor, in parallel with increase on others, acute-phase proteins, fibrinogen, von Willebrand factor, factor VIII :C, and the erythrocyte sedimentation rate. The increase i PA inhibitor as well as other acute-phase proteins in the elderly may be significant in relation to the increased incidence of thrombotic disease.

Keywords

Fibrinolysis - Plasminogen activator inhibitor - von Willebrand factor - FVIII: C - Age

• References

• 1 Collen D. On the regulation and control of fibrinolysis. Edward Kowalski memorial lecture. Thromb Haemostas 1980; 43: 77-89
• 2 Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
• 3 Juhan-Vague I, Moerman B, De Cock F, Aillaud MF, Collen D. Plasma levels of a specific inhibitor of t-PA (and UK) in normal and pathological conditions. Thromb Res 1984; 33: 523-530
• 4 Kruithof E KO, Tran Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913
• 5 Thorsen S, Philips M. Isolation of tissue-type plasminogen activator inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor. Biochim Biophys Acta 1984; 802: 111-118
• 6 Verheijen JH, Chang G TG, Kluft C. Evidence for the occurrence of a fast acting inhibitor for tissue type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
• 7 Emeis JJ, Brommer E JP, Kluft C, Brakman P. Progress in fibrinolysis In “Recent advances in blood coagulation„. Poller L. (Ed) Vol IV 11-33 Churchill Livingstone; Edinburgh - London -Melbourne - New York: 1985
• 8 Rijken DC, Juhan-Vague I, De Cock F, Collen D. Measurement of human extrinsic plasminogen activator by a two site immunoradiomet-ric assay. J Lab Clin Med 1983; 101: 274-284
• 9 Rijken DC, Juhan-Vague I, Collen D. Complexes between extrinsic plasminogen activator and proteinase inhibitors in human plasma identified with an immunoradiometric assay. J Lab Clin Med 1983; 10: 285-294
• 10 Juhan-Vague I, Rijken DC, De Cock F, Mendez C, Collen D. Extrinsic plasminogen activator levels in clinical plasma samples. In Progress in Fibrinolysis Davidson JF, Bachmann F, Bouvier CA, Kruithof E KO. (Eds) Vol VI 65-69 Churchill Livingstone; Edinburgh - London - Melbourne - New York: 1983
• 11 Davies GC, Salzman EW. The pathogenesis of deep vein thrombosis. In Venous and arterial thrombosis Joist JH, Sherman LA. (Eds) 1-22 Grune and Stratton; New York: 1978
• 12 Juhan-Vague I, Aillaud MF, De Cock F, Philip Joet C, Arnaud C, Serradimigni A, Collen D. The fast acting inhibitor of tissue type plasminogen activator is an acute phase reactant protein. In Progress in fibrinolysis Davidson JF, Donati MB, Coccheri S. (Eds) Vol VII 146-149 Churchill Livingstone; Edinburg - London - Melbourne -New York: 1985
• 13 Kluft C, Brakman P, Veldhuyzen-Stolk EC. Screening of fibrinolytic activity in plasma euglobulin fraction on the fibrin plate. In Progress in chemical fibrinolysis and thrombosis Davidson JF, Samama MM, Desnoyers PC. (Eds) Vol II 57-65 Raven Press; New York: 1976
• 14 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
• 15 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator inhibitor, or increased concentration of plasminogen activator inhibitor. Brit Med J 1985; 290: 1453-1455
• 16 Stalder M, Hauert J, Kruithof E KO, Bachman F. Release of vascular plasminogen activator (v-PA) after venous stasis, electrophoretic zymographic analysis of free and complexed v-PA. Brit J Haematol 1985; 61: 169-176
• 17 Hamilton PJ, Dawson AA, Ogston D, Douglas AS. The effect of age on the fibrinolytic enzyme system. J Clin Path 1974; 27: 326-329
• 18 Meade TW, Chakrabarti R, Haines AP, North W RS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Brit Med J 1919; 1: 153-156
• 19 Bongrand P, Bartolin R, Bouvenot G, Arnaud C, Delboy C, Despieds R. Effect of age on different receptors and functions of phagocytic cells. J Clin Lab Immunol 1984; 15: 45-50
• 20 Balleisen L, Bailey J, Epping PH, Schulte H, Van De Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemostas 1985; 54: 475-479
• 21 Aillaud MF, Juhan-Vague I, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Collen D. Increased PA-inhibitor levels in the postoperative period - no cause-effect relation with increased cortisol. Thromb Haemostas 1985; 54: 466-468
• 22 Kluft C, Verheijen JH, Jie A FH, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45: 605-610
• 23 Stuart J. The acute phase reaction and haematological stress syndrome in vascular disease. In Int J Microcirc: Clin Exp Martinus Nijhoff. (Eds) Vol III 115-129 Boston: 1984